2|0|Public
50|$|<b>Metallibure</b> (INN) (brand names Aimax, Suisynchron, Turisynchron; former {{developmental}} code names ICI-33,828, AY-61122, NSC-69536), or methallibure (USAN, BAN) is a nonsteroidal antigonadotropin {{that was}} introduced in 1973 and is used in veterinary medicine to synchronize estrus. It was withdrawn in the United States and Europe due to teratogenicity and has been replaced with altrenogest. The precise mechanism of action of <b>metallibure</b> is unknown. However, it appears to act directly on the pituitary gland and/or hypothalamus to suppress gonadotropin secretion.|$|E
50|$|<b>Metallibure</b> is {{similarly}} effective as an antigonadotropin in women. It {{is associated with}} several unpleasant side effects including anorexia, nausea, occasional vomiting, lethargy, and drowsiness. Animal toxicity studies revealed that the drug induced the development of cataracts, and this resulted in the termination of its clinical development.|$|E

